Zepbound is FDA-approved for both chronic weight management and sleep apnea. tr8ck tracks your injections, weight, sleep quality, side effects, protein intake, and more — with AI correlation that shows you the complete picture of what tirzepatide is doing for your health.
Understanding what you're taking and why shapes what you should track. Zepbound and Mounjaro are both tirzepatide — but their approved uses differ, and for Zepbound users treating sleep apnea, sleep tracking is especially meaningful.
In 2025, Zepbound became the first medication ever FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity. Clinical trials showed the drug significantly reduced apnea-hypopnea index (AHI) scores alongside weight loss.
If you're using Zepbound partly to address sleep apnea, tracking subjective sleep quality from day one creates a compelling record of improvement. tr8ck's sleep module logs quality, timing, and refreshedness — metrics that show whether your sleep is improving as your weight decreases, even before your next sleep study.
Five data streams that work together to give you the complete Zepbound health picture.
Log each weekly injection with dose. This is the timeline anchor. All other data — sleep, mood, energy, weight — gets correlated against it. After 8 weeks, tr8ck shows your personal response pattern at each dose level.
Same day, same time weekly. Daily tirzepatide weight fluctuates significantly — weekly trendlines show true progress. Overlaid with your injection history, you see which weeks produced most movement and why.
If Zepbound is addressing your sleep apnea, sleep tracking is your primary outcome measure. Log quality, timing, and how refreshed you feel each morning. The progression over 12 months is your data story of treatment response.
Tirzepatide's rapid weight loss increases muscle loss risk. Daily protein tracking ensures you're preserving muscle while losing fat. Target 0.7–1g per lb of goal body weight, logged in tr8ck's nutrition module.
Side effects are worst in weeks 1–3 at each new dose. Daily energy and mood logs create a precise map of how your body responds at each escalation step — useful data to share with your prescriber when deciding whether to proceed to the next dose.
Nausea on tirzepatide increases dehydration risk. Reduced total food and drink intake can leave users chronically under-hydrated, amplifying fatigue. Logging daily water intake surfaces this pattern quickly.
Correlations that are invisible when your health data lives in separate apps or isn't tracked at all.
For Zepbound users treating sleep apnea, this is the central question. tr8ck plots your sleep quality scores alongside your weight trend over months, showing whether the two are moving together — an early proxy for treatment response before your next clinical sleep study.
Some Zepbound users find that smaller, protein-rich meals on and around injection day reduce nausea severity. Your tr8ck data can confirm or refute whether this holds for you specifically — real personalized data vs. general forum advice.
Some users tolerate the 7.5→10mg transition easily but struggle with 10→12.5mg. Others have the opposite pattern. Your tr8ck energy and mood data across dose transitions maps your personal escalation response — invaluable when discussing pace with your prescriber.
If weight is dropping faster than 1–1.5% of body weight per week and protein intake is low, you may be losing significant muscle. tr8ck correlates your protein data with your weight loss rate to flag this risk before it becomes a problem.
Injection tracking, sleep quality, weight trend, protein intake, mood, exercise, and AI insights — all connected in tr8ck.
Also see: Zepbound Tracker · Mounjaro Tracker · GLP-1 Tracker · Sleep Apnea Tracker
They are the same molecule — tirzepatide — with different FDA indications. Mounjaro is approved for type 2 diabetes. Zepbound is approved for chronic weight management and (since 2025) for moderate-to-severe obstructive sleep apnea in adults with obesity. Same dose escalation, same side effects, different prescription pathway.
The best Zepbound app tracks the complete picture tirzepatide affects — injections, weight, sleep quality (especially important for sleep apnea users), protein intake, mood, and energy. tr8ck correlates all of these and shows you patterns that are invisible when these metrics live in separate apps.
Yes — Zepbound received FDA approval for moderate-to-severe OSA in 2025, making it the first medication approved for this condition. Clinical trials showed significant AHI reductions alongside weight loss. Tracking sleep quality in tr8ck from day one creates your personal improvement record — valuable between clinical sleep studies.
Weekly weigh-ins, same day and time. Daily weight on tirzepatide fluctuates too much to be meaningful. tr8ck overlays your weekly weight trendline with injection history and nutrition data, showing which weeks produced most movement and identifying contributing patterns.
Most common: nausea (worst weeks 1–3 at each new dose), fatigue during dose transitions, GI discomfort. Side effects diminish significantly after the body adjusts to each dose. Tracking energy and mood in tr8ck maps your personal side effect pattern at each dose level — useful for planning and prescriber conversations.
Free during early access. Injection log, sleep quality, weight trend, protein tracking, and AI insights — all connected.
Try tr8ck FreeAlso worth reading